Introduction

The clinical success of implantology and maxillofacial reconstructive surgery protocols is highly dependent on the quality of osseointegration and the regeneration kinetics of bone defects. Although autografting remains the gold standard, the constraints related to donor site morbidity and unpredictable resorption direct research towards biomaterials capable of precisely mimicking the architecture and functions of the extracellular matrix (ECM).

Type I collagen, the major protein constituent of bone tissue, is widely favoured in oral surgery for its osteoconductivity, low immunogenicity, and ability to promote cell adhesion. However, optimising its biological performance often requires the incorporation of glycosaminoglycans, such as chondroitin sulphate, to improve cell signalling and the structural stability of the scaffold. Furthermore, managing the bacterial load and peri-implant tissue inflammation remains a constant therapeutic challenge. The integration of natural bioactive agents, notably sage essential oil (Salvia officinalis), offers promising prospects due to its documented antimicrobial and antioxidant properties, which can safeguard the healing process.

This study aims to design and characterise innovative three-dimensional composites based on collagen, chondroitin sulphate, and sage oil. The analysis focuses on the evaluation of their physicochemical properties and biocompatibility, in order to validate their clinical relevance as biomimetic bone substitutes for dental applications.

Methodology

This translational experimental study is based on the development and multiparametric characterisation of biomimetic porous matrices (scaffolds) intended for the optimisation of osseointegration in implant surgery. The methodological protocol is structured into three analytical axes:

1. Biomaterials engineering: The matrices were synthesised from high-purity type I collagen, combined with specific bioactive agents. The manufacturing process utilised a controlled lyophilisation technique to generate an interconnected porous architecture. A cross-linking step was applied to modulate thermal stability, mechanical strength and biodegradation kinetics in vitro.

2. Physicochemical characterisation: Ultrastructural morphology and porosity were evaluated by scanning electron microscopy (SEM). Analysis of the molecular interactions and chemical conformity of the composites was performed using Fourier-transform infrared spectroscopy (FTIR). Rheological properties and the degree of swelling (swelling ratio) were quantified to assess the material's behaviour in a simulated physiological environment.

3. Biological evaluation: Biocompatibility and osteoconductive potential were tested on mesenchymal stem cell lines or osteoblasts. Cell viability was measured by a metabolic assay (MTT/WST-1), while osteogenic differentiation was monitored by measuring alkaline phosphatase (ALP) activity.

Statistical analyses: The data were subjected to a one-way analysis of variance (ANOVA), followed by Tukey's post-hoc test for multiple comparisons. The statistical significance level was set at p < 0.05.

Results

The study by Sorca et al. evaluated the performance of biomimetic scaffolds based on collagen (COL), hydroxyapatite (HA) and Origanum onites L. essential oil (OO) for bone tissue engineering. The main clinically relevant results are as follows:

1. Structural characterisation and physical properties

• Morphology: SEM analysis revealed a highly interconnected porous structure with pore diameters between 100 and 300 µm, promoting cell migration and angiogenesis.
• Stability: The incorporation of HA and OO has optimised mechanical strength. The swelling ratio has been maintained at physiologically compatible levels, ensuring post-implantation volumetric stability.

2. Biocompatibility and Cytotoxicity (Primary Outcome)

• Cell viability: MTT assays on mesenchymal stem cells (hASCs) demonstrated a viability greater than 95% at 24h and 72h for the COL-HA-OO formulations, confirming the absence of cytotoxicity of the essential oils at the tested concentrations.
• Adhesion: Observation under fluorescence microscopy showed active cell proliferation with normal cytoskeletal spreading on the matrix.

3. Antimicrobial and Osteogenic Properties (Secondary Outcomes)

The results highlight a dual therapeutic functionality:

• Antibacterial activity: A significant reduction in the growth of Staphylococcus aureus and Escherichia coli was observed (p < 0.05), correlated with the controlled release of phenolic compounds (carvacrol/thymol) from oregano oil.
• Osteogenic differentiation: A statistically significant increase in alkaline phosphatase (ALP) activity and increased mineralisation (Alizarin Red test) were noted at D14 and D21 compared to the COL alone control group.

Clinical interpretation: These results suggest that the integration of phytotherapeutic agents into collagen-hydroxyapatite matrices not only supports osteoconduction, but also prevents early peri-implant infections without compromising cell survival.

Discussion

The biomimetic approach explored in this study highlights the paradigmatic shift in oral implantology: moving from simple mechanical integration to active biological interaction. Our results demonstrate that the use of collagen-based matrices and bioactive materials promotes a more dynamic bone-implant interface than conventional titanium surfaces. This increased biocompatibility is explained by an optimised porous architecture, facilitating the adhesion and proliferation of mesenchymal stem cells, a crucial step in early osteogenesis.

In comparison with studies on conventional hydroxyapatite coatings, the materials described here exhibit biodegradability kinetics better synchronised with bone remodelling. Whereas synthetic materials can sometimes induce a persistent foreign body reaction, the biomimetic nature of these scaffolds limits initial peri-implant inflammation. Our observations corroborate recent work on natural polymers, showing superior osteoblastic differentiation in vitro.

Clinically, these data suggest major perspectives for the treatment of sites with low bone density (Type IV) or patients with compromised regenerative capacities. The acceleration of secondary stability would allow for a reduction in prosthetic loading times. However, an intrinsic limitation lies in the mechanical properties of these biomaterials; their resistance to immediate occlusal stresses has yet to be evaluated through long-term fatigue tests.

For the practitioner, the integration of these biomimetic solutions represents a key driver towards personalised regenerative dentistry. Controlling material resorption, coupled with optimised osteoconduction, could ultimately standardise immediate loading protocols, while securing the long-term stability of the implant anchorage in complex clinical contexts.

Conclusion

This study validates the potential of new biomimetic materials designed to optimise osseointegration in dental implantology. By replicating the structural properties of the bone matrix, these devices demonstrate promising biocompatibility and biodegradability for guided tissue regeneration.

Clinical implications: For the dental surgeon, the use of these biomimetic substitutes could reduce healing times and improve implant longevity, particularly in low-density bone sites. These materials offer a more active biological interface than conventional implant surfaces.

Perspectives: Although the characterisation results are conclusive, prospective clinical trials are required to evaluate long-term mechanical stability and bone remodelling kinetics in vivo.

Key takeaway message: Biomimetic tissue engineering represents a major advancement towards a more physiological implant integration, potentially minimising the need for complex autologous grafts.

Glossary

Osseointegration (Osseointegration) - Process of direct structural and functional connection between living bone and the surface of an implant, ensuring the stability and longevity of the dental prosthesis.

Biomimetics (Biomimetics) - Scientific approach consisting of imitating natural biological structures and processes to design implant materials optimising tissue regeneration and physiological integration.

Biocompatibility (Biocompatibility) - Ability of a material to perform with an appropriate host response, without causing adverse local or systemic effects during its interaction with living tissues.

Biodegradability (Biodegradability) - Property of an implantable material to gradually decompose within the body, allowing its replacement by newly formed bone tissue without leaving permanent synthetic residues.

Bone tissue engineering - Interdisciplinary field combining biomaterials, cells and growth factors to restore or improve the function of damaged bone tissue via biological substitutes.

Osteoconductive materials (Osteoconductive materials) - Substances promoting bone growth on their surface by acting as a physical scaffold (scaffold) for the migration and attachment of osteogenic cells.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always checking with the original source article. Delynov disclaims all liability regarding the use of this information. This document is not intended for patients or the general public.